Literature DB >> 23379571

The role of intravenous acetaminophen in multimodal pain protocols for perioperative orthopedic patients.

Paul F Lachiewicz1.   

Abstract

Multimodal pain management should be considered for all perioperative orthopedic patients. The goal of reducing the amount of perioperative opioid medication given may be achieved by using nonopioid medications, including intravenous acetaminophen. The site of action of acetaminophen is a variety of receptors in the central nervous system. When given intravenously, acetaminophen produces a much higher plasma concentration, which then leads to higher levels in the cerebrospinal fluid. The safety profile and relative lack of systemic adverse reactions make this an attractive analgesic for a wide variety of orthopedic surgical patients. Clinical studies have demonstrated the efficacy and safety of intravenous acetaminophen in elective total hip and knee arthroplasty, knee arthroscopy, lumbar spine surgery, and for acute traumatic limb pain. Copyright 2013, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23379571     DOI: 10.3928/01477447-20130122-52

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  9 in total

1.  Effect of Intravenous Paracetamol on Opioid Consumption in Multimodal Analgesia After Lumbar Disc Surgery: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Feng Yin; Xiu-Hong Wang; Fei Liu
Journal:  Front Pharmacol       Date:  2022-05-23       Impact factor: 5.988

2.  Analgesic effect of paracetamol combined with low-dose morphine versus morphine alone on patients with biliary colic: a double blind, randomized controlled trial.

Authors:  Mohammad Reza Farnia; Rasoul Babaei; Farzaneh Shirani; Mehdi Momeni; Majid Hajimaghsoudi; Elnaz Vahidi; Morteza Saeedi
Journal:  World J Emerg Med       Date:  2016

3.  Similar Outcomes After Hospital-Based Same-Day Discharge vs Inpatient Total Hip Arthroplasty.

Authors:  Jonathan A Gabor; Vivek Singh; Ran Schwarzkopf; Roy I Davidovitch
Journal:  Arthroplast Today       Date:  2020-06-28

4.  Current Trends in Pediatric Spine Deformity Surgery: Multimodal Pain Management and Rapid Recovery.

Authors:  Sagar A Shah; Richard Guidry; Abhishek Kumar; Tyler White; Andrew King; Michael J Heffernan
Journal:  Global Spine J       Date:  2019-09-22

5.  Efficacy and safety of intravenous acetaminophen (2 g/day) for reducing opioid consumption in Chinese adults after elective orthopedic surgery: A multicenter randomized controlled trial.

Authors:  Feng Yin; Wei Ma; Qiao Liu; Liu-Lin Xiong; Ting-Hua Wang; Qian Li; Fei Liu
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988

6.  1H NMR Urinary Metabolomic Analysis in Older Adults after Hip Fracture Surgery May Provide Valuable Information for Patient Profiling-A Preliminary Investigation.

Authors:  Wafa Douzi; Delphine Bon; Sara Suikkanen; Paula Soukkio; Nadège Boildieu; Arja Nenonen; Markku Hupli; Katriina Kukkonen-Harjula; Benoit Dugué
Journal:  Metabolites       Date:  2022-08-12

7.  Is Scheduled Intravenous Acetaminophen Effective in the Pain Management Protocol of Geriatric Hip Fractures?

Authors:  Alexander J Bollinger; Paul D Butler; Matthew S Nies; Debra L Sietsema; Clifford B Jones; Terrence J Endres
Journal:  Geriatr Orthop Surg Rehabil       Date:  2015-09

8.  Comparison of patient-controlled epidural analgesia and patient-controlled intravenous analgesia after spinal fusion surgery: a meta-analysis of randomized controlled trials.

Authors:  Peng Tian; Xin Fu; Zhi-jun Li; Xin-long Ma
Journal:  BMC Musculoskelet Disord       Date:  2015-12-15       Impact factor: 2.362

Review 9.  Perioperative bleeding and non-steroidal anti-inflammatory drugs: An evidence-based literature review, and current clinical appraisal.

Authors:  Ketan R Sheth; Nicholas M Bernthal; Hung S Ho; Sergio D Bergese; Christian C Apfel; Nicoleta Stoicea; Jonathan S Jahr
Journal:  Medicine (Baltimore)       Date:  2020-07-31       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.